Antwerp, Belgium Final Programme - Tropical Medicine and International Health - Institute of Tropical Medicine Antwerp
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
10th European Congress on
Tropical Medicine and
International Health
Antwerp, Belgium
16-20 October 2017
Final Programme
www.ECTMIH2017.be
Table of Contents
Committees .......................................................................................................... 4
Welcome Address ................................................................................................ 5
Legend .................................................................................................................. 6
ECTMIH 2017 Colour Codes & Tracks ....................................................................................... 7
Venue Floorplans ................................................................................................. 8
16-20 October 2017 • Antwerp, Belgium
Programme
Monday
Opening Session................................................................................ 11
Tuesday
Programme at a Glance..................................................................... 12
Programme........................................................................................ 14
Wednesday
Programme at a Glance..................................................................... 40
Programme........................................................................................ 42
Thursday
Programme at a Glance..................................................................... 64
Programme........................................................................................ 66
Friday
Programme at a Glance..................................................................... 92
Scan to download
Programme........................................................................................ 94
Posters
Poster List Tuesday....................................................................................... 103
Poster List Wednesday................................................................................. 119
Poster List Thursday..................................................................................... 136
Satellite Symposia & Meetings ........................................................................... 155
Exhibitors & Sponsors ........................................................................................ 158
Available for
General Information............................................................................................. 163
ECTMIH 2017 Registration................................................................................................... 165
Social Activities............................................................................................. 166
General Information....................................................................................... 167
www.ectmih2017.be www.ectmih2017.be 3
Congress Chair ECTMIH2017: World-Class Science for World-Wide Development
Bruno Gryseels, Director, Institute of Tropical Medicine, Antwerp, Belgium
From 16 to 20 October 2017, some 1500 scientists and experts from all over the world
Chair Scientific Boards
will come together in Antwerp for the 10th European Congress on Tropical Medicine
Anne Buvé, Head, Department of Public Health, Institute of Tropical Medicine, Antwerp,Belgium
and International Health. They will share the state of the art and new research results
Scientific Committee (Track Coordinators) in tropical medicine and public health in developing countries, these exciting scientific
Kevin Ariën, Head, Unit of Virology, Department of Biomedical Sciences, Institute of Tropical fields which contribute so much to the advancement of human development and the
Medicine, Belgium understanding of evolutionary medicine.
Emmanuel Bottieau, Head, Unit of Tropical Diseases Department of Clinical Sciences Institute of
Tropical Medicine, Antwerp, Belgium More than 100 sessions will deal not only with long-standing topics as malaria, tuberculosis,
Xavier de Béthune, Medical Director, Médecins du Monde, Belgium
parasitic diseases, tropical bacteria, haemorrhagic and vector-borne viruses, but also with
Marleen Boelaert, Head, Unit of Epidemiology and Control of Tropical Diseases, Institute of Tropical
Medicine, Belgium
their ramifications in world-wide challenges as antimicrobial resistance, universal health
Faustin Chenge, Ecole de Santé Publique, Université de Lubumbashi, RDC care, epidemic responsiveness, migration and climate change. In a unique interdisciplinary
Marc Coosemans, Head, Unit of Entomology, Institute of Tropical Medicine, Antwerp, Belgium context, data will be presented from research laboratories and the clinical bedside as
Bart Criel, Head, Unit of Equity and Health, Institute of Tropical Medicine, Antwerp, Belgium well as from the community and policy levels. As in no other field, the excellence of the
Olivier Denis, Clinical Microbiologist, Chirec and Professor at Université Libre de Bruxelles, Belgium science will be matched by its societal impact at local, national and international level.
Philippe Donnen, Ecole de Santé Publique, Université Libre de Bruxelles, Belgium
Jean-Claude Dujardin, Head, Department of Biomedical Sciences, Institute of Tropical Medicine,
Besides the listed sessions, there is ample opportunity for informal exchanges and
Belgium
Sarah Gabriël, Professor, Faculty of Veterinary Sciences, University of Ghent, Belgium
discussion in the beautiful halls of the Elisabeth Centre and in the adjacent, freely
Eduardo Gotuzzo, Director, von Humboldt Institute of Tropical Medicine, Lima, Peru accessible Zoo of Antwerp. The meeting will give a prominent floor to scientists from the
John Gyapong, Vice Chancellor, University of Health and Allied Sciences, Ghana South and to young international researchers.
Karel Gyselinck, Chair, Be-Cause Health; Belgian Technical Cooperation, Belgium
Christian Lengeler, Department Head, Swiss Tropical and Public Health Institute, Basel, Switzerland Antwerp's nickname among its citizens is "the metropole", in spite of its modest size. Over
Hechmi Louzir, Director, Pasteur Institute, Tunis the past ten centuries, it has been a port of access to the heart of Europe for merchants,
Lut Lynen, Head, Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium
travellers and migrants from all over the world. Its history and spirit are reflected in its
Bruno Marchal, Head, Unit of Health Services Organisation, Department of Public Health, Institute of
Tropical Medicine, Belgium
marvellous city centre, splendid museums, elegant shopping streets and hundreds of
José Muñoz, Head, Tropical Medicine and International Health, Hospital Clínic, Barcelona, Spain excellent restaurants and cafés.
Jorge Perez Avilla, Director, Pedro Kouri Institute of Tropical Medicine, Havana, Cuba
Inger Scheel, President, Norwegian Forum for Global Health Research, Norway (FESTMIH)
Pierre Van Damme, Head, Department of Vaccinology, University of Antwerp, Belgium We wish you excellent and relevant science, and a wonderful stay in Antwerp.
Wim Van Damme, Head, Unit of Health Policy, Department of Public Health, Institute of Tropical
Medicine, Antwerp, Belgium
Chris Van Geet, Head, Department of Pediatrics, Catholic University of Leuven, Belgium
Annelies Van Rie, Professor, Global Health Institute, University of Antwerp, Belgium
For the organisers,
Prof Bruno Gryseels
ITM Organising Committee Official Organiser Congress Chair
Jean-Christophe Donck (Chair) MediCongress Services NV
Naima Al Bdiouni Noorwegenstraat 49
Nathalie Brouwers 9940 Evergem, Belgium
Vicky Croonen www.medicongress.com
Cleo Maerivoet info@medicongress.com
Roeland Scholtalbers
Nico Van Aerde
Ann Van Gyseghem
Eline Van Meervenne
Niki Vanwesenbeeck
4 www.ectmih2017.be www.ectmih2017.be 5
Legend Colour Codes & Tracks
Track 1. Breakthroughs and innovations in tropical biomedical sciences
The programme is organised in 8 tracks. These 8 tracks are listed on page 7. You will • Molecular biology and epidemiology
find the track numbers (1 to 8) in the session codes. • Vector biology
• Diagnostic and therapeutic innovations
• Immunology
There are 4 types of sessions, coded as S, OS, IPS and LBS: • Vaccinology
Track 2. Ecology of tropical disease agents
• S sessions are composed of oral presentations selected via the Call • One health
for Abstracts • Transmission dynamics
• Vector ecology
1S1 = Session 1 in track 1 • Human ecology
1S2 = Session 2 in track 1 Track 3. State of the art in clinical tropical medicine
• Novel diagnostics, drugs, vaccines
• OS sessions are sessions selected via the Call for Organised Sessions • Travel and migrant health
• Quality assurance of products and procedures
1OS1 = Organised Session 1 in track 1 • Biosafety and biosecurity
• Clinical trials, ethics and regulation
1OS2 = Organised Session 2 in track 1 • Nursing and patient care
• IPS sessions are Interactive Poster Sessions in which the best Posters Track 4. Control, elimination and eradication sciences
will be briefly presented • State of the art in the control of tropical diseases, TB and HIV
• Theory and practice of elimination and eradication
• Social sciences, the human factor and community involvement
1IPS1 = Interactive Poster Session 1 in track 1 • Sustainability and integration of control strategies
2IPS1 = Interactive Poster Session 1 in track 2 • Economic and political considerations
• LBS sessions are Late Breaker Sessions and are composed of oral and Track 5. Health systems and public health
poster presentations selected via the Call for Late Breaker Abstracts • Financial, human and material resources for health
• Quality management and regulation, including drugs and diagnostics
• Management and integration of disease-specific programmes including NCD’s
LBS1 = Late Breaker Session 1 • Access, equity, sustainability and resilience
LBP = Late Breaker Poster • Digitalisation and e-health
• National health policies and governance
Furthermore each track has been given a different colour (see page 7). When you look at
Track 6. International health collaboration
the day-by-day programme at a glance you can easily find the track and sessions you • The role of international cooperation in health development
are interested in. • Instruments of international health cooperation
• The position of tropical institutes and global health centres
• Funding, governance and ownership
• Ownership, principles and ethics in international health
• Evidence-based humanitarian and emergency aid
Track 7. Global health
• Global health inequity and Universal Health Coverage
• Demographics and migration
• International trade and the global economy
• Environmental, urban and industrial health
• Global health policies and governance
Track 8. Integrated and other subjects
• Social sciences in health related research
• Reproductive and maternal health
• Child health and nutrition
• Subjects not captured by any of the other tracks
• Subjects integrating or covering several of the above themes
6 www.ectmih2017.be www.ectmih2017.be 7
8
CLOAK ROOM
CLOAKROOM
EXHIBITION
EXHIBITION
POSTERS
SPEAKER
SPEAKER POSTERS
ROOM
ROOM
www.ectmih2017.be
GROUND FLOOR
REGISTRATION
REGISTRATION
ENTRANCE
ENTRANCE
GORILLA
Gorilla 5 5
1.5.5
Gorilla
GORILLA
1.5.4 4 4 1.1
1.6.1
1.6
1.6.2
1.5
GORILLA 3
Gorilla 3
1.5.3
GORILLA
Gorilla1 1
Press 1.5.1
PRESS
Room
www.ectmih2017.be
1.4
FIRST FLOOR
1.10
E-ROOM
e-Room 1 1
Stanley
STANLEY
1.3
9
Monday Tuesday Wednesday Thursday Friday Posters
SECOND FLOOR Elisabeth
15.00 Registration
17.00 Opening Session
With music by Belgium’s most important wind ensemble, I Solisti Belgian wind ensemble Antwerp
Master of Ceremony: Bharathi Ghanasyam
Freelance Journalist India & 2015 Journalist-in-Residence at the Institute of Tropical Medicine (ITM),
Antwerp
GALAPAGOS
Welcome Addresses
e-Room 2 2
DARWIN
Galapagos
E-ROOM
Darwin
Official Opening of the Congress
Bruno Gryseels (Congress Chair, ITM Director)
Cathy Berx (Governor of the Province of Antwerp)
A word from the Federation of European Societies of Tropical Medicine and International Health
Karel Gyselinck (President of FESTMIH)
Introduction to the programme
Anne Buvé (Chair of the Scientific Committee, ITM)
A new generation in global health: Views from Africa, Asia, Latin America and
Europe
Aku Kwamie (Research Consultant, Health Policy and Systems Research, Ghana)
Vijayashree Yellappa (Institute of Public Health, India)
Dalila Martinez (Instituto de Medicina Tropical Alexander von Humboldt, Peru)
Conor Meehan (Institute of Tropical Medicine Antwerp, Belgium/Ireland)
Keynote Lectures
Leadership and ownership in tropical health research
Rose Leke (Emeritus Professor of Immunology and Parasitology and Director of the Biotechnology
Centre at the University of Yaoundé, Cameroon)
The past, present and future of tropical diseases in Europe
Denis Coulombier (Head of Unit for Surveillance and Response Support, European Centre for Disease
Prevention and Control, Stockholm, Sweden)
19.00 Welcome Reception
PELICAN
Pelican
TOUCAN
NIGHTINGALE
Toucan
Nightingale
PEACOCK
Peacock
10 www.ectmih2017.be www.ectmih2017.be 11
Programme at a glance - Tuesday 17/10
Elisabeth Hall Nightingale Darwin Gorilla 1 Gorilla 3 Pelican
08.30 - 10.00 Plenary Talks
10.00 Coffee Break
3S3 5OS2 1S1
3S1 4S1 5S1
Experiences in Diagnostics 1
10.30 - 12.00 Arboviruses Malaria Elimination of Digitalisation
capacity building - Serology and
(clinical) HAT and e-Health hemo-culture
12.00 Lunch Break & Poster Tour (12.30 - 13.30) / Satellite Symposium (see page 155)
12.30
4OS1
Phase II/III results 5S2 6OS1
for fexinidazole, Building capacity 1S2
3S2 3OS2 Patients,
the first oral for policy Diagnostics
Ebola and other New Clinical Communities influence and
13.30 - 15.00 treatment for
Developments and Health 2 - DNA-based
viruses human African health systems
of Antimalarials trypanosomiasis Services assays
management
(HAT)
15.00 Coffee Break
3OS1 3OS3
Zika: 8S1 4S2 5OS1 6OS2 Raising standards
Outbreak Patient Health and quality
epidemiology Malaria in of Parasite
15.30 - 17.00 surveillance Centered Care cooperation
and clinical Pregnancy diagnostics in
and response (PCC) beyond aid non-endemic
manifestations clinical settings
using molecular
and lateral flow
1OS1 technologies
4S3 4S4
Zika: Basic 8S2 5S3
Spatial Biosocial 3OS4
17.00 - 18.30 science Malaria in New developments
analysis Health Policies approaches in
and social Children in the diagnosis of
approaches disease control imported parasitic
implications infections in Europe
Programme at a glance - Tuesday 17/10
Toucan Gorilla 4 Gorilla 5 e-Room 1 e-Room 2
Stanley Galapagos
08.30 - 10.00
10.00 Coffee Break
8S3 4IPS1
2S1 3OS5 5IPS1
Sexual and Interactive Poster
Surveillance of Nodding Interactive Poster
10.30 - 12.00 Reproductive Session 1 -
syndrome Session 1 -
arboviruses Health Rights Track 4
Track 5
12.00 Lunch Break & Poster Tour (12.30 - 13.30) / Satellite Symposium (see page 155)
12.30
2S2 8S4 5IPS2
9S1 4IPS2
Vectors and Sexual and Interactive Poster Interactive Poster
13.30 - 15.00 transmission of Emerging voices Session 2 -
Reproductive Session 2 -
arboviruses Health Track 5 Track 4
15.00 Coffee Break
8OS1
Abortion and 6/7IPS1 3IPS1
2S3 post abortion Interactive Interactive Poster
15.30 - 17.00 Trematodes care: Politics, Session 1 -
Poster Session Track 3
religion, public - Track 6/7
health, health
care and legal
systems
2S4 9S3 3OS6 3IPS2
17.00 - 18.30 Onchocerciasis Training on Integrating mental Interactive Poster
8S5 Session 2 -
& Modelling Neglected health into local
HIV health systems Track 3
Tropical
Diseases
Monday Tuesday Wednesday Thursday Friday Posters Monday Tuesday Wednesday Thursday Friday Posters
Elisabeth Elisabeth
08.30 Plenary Talks 13.30 3S2 - Ebola and other Viruses
Chairs: Shyam Sundar (India) and Elisabeth Paul (Belgium) Chairs: Alexandre Delamou (Belgium) and Johan van Griensven (Belgium)
New tools for vector control 3S2.1 Which personal protective equipment to provide? – Challenges during the ebola
Steven W. Lindsay, Durham University, UK outbreak and lessons learned
Lee M.H., Meerbach A., Straub J., Neidhardt I., Gresser N., Gies S., Verbeek L. (Germany)
Debate: Doing development differently: The future role of international cooperation
Christine Kirunga Tashobya, Makerere School of Public Health, Uganda 3S2.2 Inclusion of pregnant women in ebola clinical trials
Jan Paehler, EuropeAid, DG DEVCO, European Commission Caluwaerts S., Ebola Investigational Platform, Ronsse A., Lagrou D., Antierens A. (Belgium)
Remco van de Pas, Institute of Tropical Medicine, Belgium
3S2.3 Human T-lymphotropic virus 1 and 2 infections among patients with neurological disorders
10.00 Coffee Break in the Democratic Republic of the Congo
Verdonck K., Mukendi D., Barbé B., Ariën K., Yansouni C.P., Lutumba P., Boelaert M., Chappuis F.,
Muyembe J.J., Bottieau E. (Belgium, Democratic Republic of Congo, Canada & Switzerland)
10.30 3S1 - Arboviruses
Chairs: Annelies Wilder-Smith (Sweden) and Denis Malvy (France) 3S2.4 Presence of defective HTLV-1 provirus in Peruvian asymptomatic carriers
Mora R., Rosado J., Falconi-Agapito F., Ocampo C., Gotuzzo E., Alvarez C., Talledo M. (Peru)
3S1.1 Comparison of laboratory and clinical Dengue virus strains reveals major
differences in endothelial cell pathology 3S2.5 The clinical characterization of human monkeypox infections in the Democratic Republic
Vervaeke P., Noppen S., Meyen E., Ariën K.K., Liekens S. (Belgium) of Congo
Mbala K.P., Huggins W.J., Riu R.T., Mulembakani M.P., Ahuka M.S., Kumakamba M.C., Martin W.J.,
3S1.2 Clinical features of Chikungunya infection and chronic polyarthralgia after the 2014- Muyembe T.J.J. (DRC & USA)
2015 outbreak on Aruba
Huits R., De Kort J., Van Den Berg R., Chong L., Eggermont K., Ariën K., Cnops L., 3S2.6 Aids-related systemic mycoses endemic to Western Cape, South Africa and clinical
Jacobs J., Van Esbroeck M., Bottieau E. (Belgium & Aruba) mimics: A cross-sectional study of adults with advanced HIV and recent-onset,
widespread skin lesions
3S1.3 Detection of Zika virus NS1 antigen in semen by a prototype rapid test Schwartz I.S., Kenyon C.R., Claasens S., Spengane Z., Lehloenya R., Prozesky H.W.,
Cnops L., Nakayama E.E., Caron E., Eggermont K., Van Esbroeck M., Bottieau E., Colebunders R., Dlamini S. (Belgium, Canada & South Africa)
Jacobs J., Shioda T., Huits R. (Belgium & Japan)
3S1.4 Epidemiological and clinical data of children exposed to Zika virus registered in 15.00 Coffee Break
Spanish database. How often is microcephaly?
Soriano-Arandes A., García López-Hortelano M., Frick M.A., Prieto Tato L., Fumadó V.,
Navarro M.L., Sulleiro E., Martín-Nalda A., Mellado M.J., Soler-Palacín P. (Spain) 15.30 3OS1 - Zika: Epidemiology and Clinical Manifestations
3S1.5 Surveillance of Zika virus in pregnant women returning from affected areas: Results Organisers:
from a cohort study in Southern Europe Jointly organised by three Zika related research consortia funded under Horizon 2020 by
Marbán-Castro E., Goncé A., Martínez M.J., Fumadó V., Esteve C., Fortuny C., López M., the European Commission
García L., Salazar L., Salvia D., Oliveira I., Rodríguez-Valero N., Pinazo M.J., Requena-
Méndez A., Llenas-García J., Alejo-Cancho I., Saco A., Castillo P., Fuente-Moreno M., Chairs:
Casellas A., González R., Muñoz J., Gascón J., Ordi J., Menéndez C., Bardají A. (Spain) Annelies Wilder-Smith (Sweden) and Carlo Giaquinto (Italy)
3S1.6 Incidence of travel-associated Zika virus infection in 2016: Preliminary results of a 3OS1.1 ZikaPLAN introduction - Epidemiology and geographic spread
prospective cohort study in Belgian travellers to the Americas Wilder-Smith A. (Sweden)
Huits R., Van Den Bossche D., Feyen A., Potters I., Lotgering E., Eggermont K., Cnops L.,
Jacobs J., Van Esbroeck M., Bottieau E. (Belgium) 3OS1.2 ZIKAlliance introduction - Zika seroepidemiological studies
de Lamballerie X. (France)
3OS1.3 Zika virus epidemiology and geographic spread in Jamaica
12.00 Lunch Break and Poster Tour (12.30 - 13.30) Christie C.D.C. (Jamaica)
3OS1.4 Risk estimates for birth defects
Jaenisch T. Gemany)
3OS1.5 Children and Zika: How to approach this challenge after birth?
Soriano-Arandes A. (Spain)
3OS1.6 Neurological complications of Zika in adults
Solomon T. (UK)
14 www.ectmih2017.be www.ectmih2017.be 15
Monday Tuesday Wednesday Thursday Friday Posters Monday Tuesday Wednesday Thursday Friday Posters
Elisabeth Nightingale
17.00 1OS1 - Zika: Basic Science and Social Implications 10.30 3S3 – Malaria (clinical)
Chairs: Tinto Halidou (Burkina Faso) and Arjen Dondorp (Thailand)
Organisers:
Jointly organised by three Zika related research consortia funded under Horizon 2020 by 3S3.1 Vivax malaria morbidity after radical treatment: A 2-year cohort study in Central Vietnam
the European Commission Thanh P.V., Hong N.V., Xuan Xa N., Van N.V., Cleves M.A., Duong T.T., Hung L.X.,
Rosanas-Urgell A., D’Alessandro A., Speybroeck N., Erhart A. (Vietnam, USA, Belgium &
Chairs: The Gambia)
Xavier de Lamballerie (France) and Johan Neyts (Belgium)
3S3.2 P. Vivax recurrences after radical treatment in the Peruvian Amazon: A 2-year cohort
1OS1.1 Zika virus and vector competence study
Failloux A.B. (France) Erhart A., Sotto-Calle V., Delgado C., Rosas A., Rodriguez H., van Geertruyden J.P.,
Rosanas A., Speybroeck N., Gamboa D., D’Alessandro U., Llanos A. (Belgium,
1OS1.2 Zika virus replication in testicles in mice and impact of viral replication inhibitors Peru & The Gambia)
Neyts J. (Belgium)
3S3.3 Low dose primaquine efficacy and safety: A review and individual patient data meta-
1OS1.3 Neuropathogenesis in peripheral versus central nervous system analysis
Willison H. (UK) Humphreys G.S. on behalf of the WWARN Single Low Dose Primaquine Study Group (UK)
1OS1.4 Zika virus replication at the placental interface: The role of non-neutralizing 3S3.4 The consequences of censoring new infections when deriving antimalarial efficacy
immunity against uncomplicated P. Falciparum malaria
Bonfante F. (Italy) Dahal P. on behalf of the WWARN Methods Study Group (UK)
1OS1.5 The role of risk proximity in the beliefs and behaviors related to emerging infectious 3S3.5 Drug discovery towards the eradication of malaria: Harnessing the power of a
diseases: The cases of Chikungunya and Zika in French Guiana global network of partners
Raude J. (France) Abla Geiser N., Willis P.A. (Switzerland)
12.00 Lunch Break and Poster Tour (12.30 - 13.30)
13.30 3OS2 - New Clinical Developments of Antimalarials
Organisers:
Dr.Dr. Carsten Köhler, President of the German Society for Tropical Medicine and International
Health (DTG) and Director of Center of Excellence for Tropical Medicine in the state of Baden-
Württemberg; Professor Dr. Peter G. Kremsner, Malaria branch speaker of the German Center for
Infection Research (DZIF) Tübingen and Director of Institute of Tropical Medicine, University of
Tübingen; Tübingen, Germany
Chairs:
Peter G. Kremsner (Germany) and Carsten Köhler (Germany)
3OS2.1 Controversies around artemisinins
Krishna S. (UK)
3OS2.2 State-of-the-art of the clinical development of KAF156, a novel antimalarial
Grobusch M.P. (The Netherlands)
3OS2.3 OZ-Piperaquine as single dose antimalarial: A multinational phase IIb study
Ramharter M. (Austria)
3OS2.4 DSM265, a promising novel antimalarial compound for chemoprophylaxis
Sulyok M. (Germany)
3OS2.5 Fosmidomycin-piperaquine as non-artemisinin-based combination therapy for
acute uncomplicated Plasmodium falciparum malaria
Mombo-Ngoma G. (Gabon)
15.00 Coffee Break
16 www.ectmih2017.be www.ectmih2017.be 17
Monday Tuesday Wednesday Thursday Friday Posters Monday Tuesday Wednesday Thursday Friday Posters
Nightingale Darwin
15.30 8S1 - Malaria in Pregnancy 10.30 4S1 - Elimination of Human African Trypanosomiasis
Chairs: Jean-Pierre Van Geertruyden (Belgium) and Sabine Gies (Germany) Chairs: Joseph Ndungu and Veerle Lejon (France)
8S1.1 Malaria in pregnancy preventive treatments may provide additional protection
4S1.1 Innovative methods of case finding to achieve elimination of human African
against febrile illnesses during the first year of life
Natama H.M., Rovira-Vallbona E., Sorgho H., Somé M.A., Coulibaly-Traoré M., trypanosomiasis in the Democratic Republic of Congo
Schallig H.D.F.H., D’Alessandro U., Kestens L., Tinto H., Rosanas-Urgell A. (Burkina Faso, Mpanya A., Claeys Y., Fukinsia A., Snijders R., Makabuza J., Boelaert M., Lutumba P.,
Belgium, The Netherlands & The Gambia) Lumbala C., Hasker E. (DRC & Belgium)
8S1.2 Safety of antimalarial drug use during early pregnancy in Bobo Dioulasso: Examining 4S1.2 Development of a framework for integrated passive surveillance to drive elimination
low birth weight and congenital malformations as potential adverse outcomes of human African trypanosomiasis in Kongo Central province, DRC
Rouamba T., Kpoda H., Valéa I., Mens P.F., Gomes M., Tinto H., Kirakoya-samadoulougou F.
Lumbala C., Kayembe S., Bessell P.R., Picado A., Biéler S., Ndung’u J.M. (DRC, UK &
(Burkina Faso, Belgium, The Netherlands & Switzerland)
Switzerland)
8S1.3 Optimal duration of follow-up for assessing efficacy of drugs for uncomplicated
falciparum malaria in pregnancy in Asia: A systematic review and individual patient 4S1.3 The conflict in South Sudan: A threat to the elimination of gambiense human African
data meta-analysis trypanosomiasis in Uganda?
Saito M., Dahal P., Tyrosvoutis M.E.G., Stepniewska K., Humphreys G.S., Paw M.K., Wamboga C., Picado A., Waiswa C., Matovu E., Torr S., Biéler S., Katz Z., Bessell P.R.,
Pimanpanarak M., Nosten F., Guerin P.J., McGready R. (UK & Thailand) Ndung’u J.M. (Uganda, Switzerland & UK)
8S1.4 Malaria screening during pregnancy with RDTs performed by community health
workers in Nanoro, Burkina Faso 4S1.4 A strategy combining passive screening and reactive screening to control human
Ruizendaal E., Schallig H.D.F.H., Traore M., Lompo P., Magloire N.H., Traore O., Valea I., African trypanosomiasis during the Ebola crisis in Guinea
Pagnoni F., Dierickx S., Scott S., Bradley J., d’Alessandro U., Tinto H., Mens P.F. (The Camara O., Camara M., Bucheton B., Camara M., Biéler S., Ndung’u J.M. (Republic of
Netherlands Burkina Faso, Switzerland, Belgium, The Gambia & UK) Guinea, France & Switzerland)
8S1.5 Malaria is more prevalent than iron deficiency among anemic pregnant women at 4S1.5 Adding Tsetse control to medical activities contributes to decreasing transmission
the first antenatal visit in rural South-Kivu
of sleeping sickness in the mandoul focus (Chad)
Bahizire E., Tugirimana P.L., Dramaix M., Zozo D., Bahati M., Mwale A., Meuris S., Donnen P.
(DRC, Belgium, Kenya & Rwanda) Rayaisse J.B., Mahamat H.M., Peka M., Rock K.S., Tirados I., Courtin F., Mahamat H.M.,
Torr S.J., Lehane M.J., Solano P. (Burkina Faso, Chad, UK & France)
17.00 8S2- Malaria in Children
Chairs: Halidou Tinto (Burkina Faso) and Anna Rosanas-Urgell (Belgium) 12.00 Lunch Break and Poster Tour (12.30 - 13.30)
8S2.1 Delivery strategies of malaria chemoprevention for post-discharge management of 13.30 4OS1 - Phase II/III Results for Fexinidazole, the First Oral Treatment
children with severe anaemia in Malawi
Gondwe T., Robbestad B., Mukaka M., Banda S., Lange S., Blomberg B., Phiri K.S. for Human African Trypanosomiasis (HAT)
(Malawi, Norway & USA)
Organiser:
8S2.2 Impact of a malaria rapid diagnostic test detecting Plasmodium falciparum-specific
histidine-rich protein-2 (RDT-PfHRP2) on the management of febrile children Nathalie Strub-Wourgaft, Drugs for Neglected Diseases initiative, Geneva, Switzerland
under-5 years of age in a high seasonal malaria transmission area
Kiemde F., Bonko A., Tahita M.C., Lompo P., Boele van Hensbroek M., Tinto H., Mens P.F., Chair:
Schallig H.D.F.H (Burkina Faso & The Netherlands) José Ramon Franco (Switzerland)
8S2.3 Safety of artesunate-amodiaquine combined with methylene blue or primaquine for
the treatment of uncomplicated falciparum malaria in young African children: 4OS1.1 Developing treatments for sleeping sickness: DNDi’s R&D strategy
A randomised controlled non-inferiority trial Strub-Wourgaft N. (Switzerland)
Mendes Jorge M., Meissner P., Ouermi L., Coulibaly B., Nebie E., Compaoré G., Kieser M.,
Klose C., Krisam J., Mockenhaupt F., Sie A., Müller O. (Germany & Burkina Faso) 4OS1.2 Results from the pivotal trial of fexinidazole: Non-inferiority shown to the gold
8S2.4 A qualitative study of the acceptability of weekly iron supplementation prior to the standard NECT
first pregnancy in Burkina Faso Tarral A. (Switzerland)
Compaore A., Gies S., Brabin B.J., Tinto H., Brabin L. (Burkina Faso, Belgium, Germany,
UK & The Netherlands) 4OS1.3 The efficacy of fexinidazole in children and stage 1 patients
Bardonneau C. (Switzerland)
8S2.5 Malaria risk in in young children after periconceptional iron supplementation of
mothers in rural Burkina Faso
Gies S., Diallo S., Tinto H., Brabin L., Roberts S., D’Alessandro U., Brabin B.J. (Belgium, 4OS1.4 Working together across continents to organize and run clinical trials in remote areas
Germany, Burkina Faso, UK, The Gambia & The Netherlands) Mutombo Kalonji W. (DRC) and Valverde Mordt O. (Switzerland)
8S2.6 Impact of micronutrient powders combined with malaria chemoprevention on 4OS1.5 The potential impact of fexinidazole on the global strategy to eliminate sleeping
anemia, malaria and cognitive development: A cluster-randomized study in
Malian children sickness
Diarra N.H., Roschnik N., Sacko M., Dicko Y., Verhoef H., Saye R., Lal S., Jones R., Boivin Lumbala C. (DCR) and Perez Simarro P. (Switzerland)
M., Clarke S.E. (Mali, UK, The Netherlands & USA)
15.00 Coffee Break
18 www.ectmih2017.be www.ectmih2017.be 19Monday Tuesday Wednesday Thursday Friday Posters Monday Tuesday Wednesday Thursday Friday Posters
Darwin Gorilla 1
15.30 4S2 – Outbreak Surveillance and Response 10.30 5S1 - Digitalisation and e-Health
Chair: Veerle Vanlerberghe (Belgium) Chair: Peter Delobelle (South Africa)
4S2.1 Developing and operationalizing national-level early warning and response systems 5S1.1 An open source API for real time drug prescription monitoring at the point of care in
(EWARS) for dengue and other Aedes-borne arboviral diseases low resource settings
Olliaro P., Kroeger A., Tozan Y., Rocklöv J. (Switzerland, Germany, USA & Sweden) Verbeke F., Van Laere S., Nyssen M. (Belgium)
4S2.2 Why the outbreak of Ebola virus disease in West Africa could have been detected 5S1.2 Defining a supervision strategy using artificial intelligence (AI) - The case of data
one month - not three - after patient zero and lessons learned for surveillance supervision for the results based financing intervention in Benin
systems strengthening Lurton G., Antony M., Legrand A., de Borman N. (USA & Belgium)
Badenschier F. (Germany & UK)
5S1.3 Primitive metrics for predicting clinical documentation performance in Burundian
4S2.3 Catching the risk of measles outbreaks in a clustered society public hospitals
Willem L., Verelst F., Kuylen E., Abboud L.A., Bicke J., Hens N., Broeckhove J., Beutels P. Verbeke F., Karara G., Van Bastelaere S. (Belgium)
(Belgium & Australia)
5S1.4 Connecting the unconnected in sub-Saharan Africa: Non-discriminating access for
4S2.5 A One Health team to improve Monkeypox virus outbreak response: An example digital inclusion with an emphasis on health (DigI)
from the Democratic Republic of the Congo Holst C., Knobloch J., Schmidt V., Mwakapeje E., Ngowi H., Ngowi B., Prazeres da Costa C.,
Laudisoit A., Verheyen E., Baelo P., Akonda I., Nebesse C., Ngoy S., Gembu G., Tepage Brügge B., Winkler A.S., Noll J. (Norway, Germany & Tanzania)
F., Muyembe J.J., Alworonga O., Mande D., Angotolwa Z., Leirs H., Ngbonda D.,
Colebunders R. (Belgium, UK & Democratic Republic of Congo) 5S1.5 Digitizing routine health facility assessment in low-resource settings
Legrand A., Nembetwa N. (Belgium)
4S2.6 The association of cholera outbreak with conflict-related factors in Yemen
Dureab F., Shabib K., Jahn A. (Germany)
12.00 Lunch Break and Poster Tour (12.30 - 13.30)
17.00
4S3 – Spatial Analysis Approaches and Modelling in Support of
Disease Control 13.30 5S2 - Patients, Communities and Health Services
Chairs: Epco Hasker (Belgium) and Elies Van Belle (Belgium) Chair: Paul Bossyns (Belgium)
4S3.1 Considering the spatial heterogeneity of dengue transmission for designing an 5S2.1 Is health protected: Life histories of vulnerable groups in fragile and conflict-
Aedes control strategy affected situations
Vanlerberghe V., Toledo M.E., Ocampo C., Manrique-Saide P., Honorio N., Vazquez- Fustukian S., Vidal N., O’May F., Amara R., Buzuzi S., Ros B., Ssali S., McPake B. (UK,
Prokopec G., Mirabal M., Alexander N., Frutuoso R.L., Van der Stuyft P. (Belgium, Cuba, Sierra Leone, Zimbabwe, Cambodia, Uganda & Australia)
Colombia, Mexico, Brazil & USA)
5S2.2 10 years of research on India’s ASHA program: A literature review framing health
4S3.2 Digitalization and planning of active HAT screening in the Democratic Republic of systems interfaces supporting a national community health worker program
Congo to reach elimination Scott K., George A., Singh S., Gupta G., Ummer O., Ved R. (India & South Africa)
Claeys Y., Makabuza J., Mpanya A., Boelaert M., Lutumba P., Lebuki J., Hasker E.,
Lumbala C. (Belgium & Democratic Replubic of Congo) 5S2.3 Reasons for not attending a health care centre for soil-transmitted helminth
infections in a rural village in Indonesia
4S3.3 Modelling to support the planning of malaria elimination in southern Palawan, the Philippines Meyanti F., Verdonck K., Polman K., Mahendradhata Y. (Indonesia & Belgium)
Briët O.J.T., Angluben R., Torno M., Navarro M.A.H., Deray R., Schapira A. (Switzerland &
Philippines) 5S2.4 Mid-term evaluation results of improvement in medical interventions and midwifery
care in five medical regions in Senegal
4S3.4 Mapping of leprosy cases as a tool for rationalizing contact screening Goto M., Matsui M., Guéye Ba M., Iino Y., Sugiura Y., Murakami H., Fukushima K., Daff B.M.,
Hasker E., Baco A., Younoussa A., Mzembaba A., Salim Z., Amidy M., Grillone S., Diack A. (Senegal & Japan)
Demeulenaere T., Ortuno-Gutierrez N., Groenen G., Suffys P., de Jong B. (Belgium,
Comoros & Brazil) 5S2.5 Integration of maternal postpartum services in maternal and child health services in
Kaya health district (Burkina Faso): An intervention time trend analysis
4S3.5 A spatial decision support system approach to implementing malaria surveillance as Yugbaré Belemsaga D., Goujon A., Tougri H., Coulibaly A., Degomme O., Duysburgh E.,
a core intervention activity in high priority Vietnam Temmerman M., Kouanda S. (Burkina Faso)
Canavati S.E., Vo T.H., Ngo Duc T., Tran D.T., Ngo T.D., Kelly G., Martin N.J. (Vietnam,
Australia, Finland & Singapore)
15.00 Coffee Break
20 www.ectmih2017.be www.ectmih2017.be 21Monday Tuesday Wednesday Thursday Friday Posters Monday Tuesday Wednesday Thursday Friday Posters
Gorilla 1 Gorilla 3
15.30 5OS1 - Patient Centered Care (PCC) 10.30 5OS2 - Experiences in Capacity Building in Public Health Institutes in
Low-Income Countries, putting Local Public Health Institutes in
Organisers: the Lead of Research for Policy Development
Bart Criel, ITM, Public Health Department and chair of the Be-cause Health People-
Centered Care working group
Evelyne Waweru, ITM, PhD student, Public Health Department Organiser:
European Commission, International Cooperation and Development-EuropeAid –
Chair: Supporting Public Health Institutes Programme (SPHIP)
Bart Criel (Belgium)
Chairs:
5OS1.1 Setting the scene for Patient-Centered Care and health systems in low and middle Kevin McCarthy (EC) and Jaap Koot (The Netherlands)
income countries
De Man J. (Belgium) 5OS2.1 Using evidence for mobilising support for NCD transition strategic plan in Myanmar
Ram Jat T. (Myanmar)
5OS1.2 A state of mind: Reflections on Patient Centered Care approaches and experiences
in the North and South 5OS2.2 Evidence for mobilising access to care for the poor in Bangladesh
Hoerée T. (Belgium) Rahman Shaheen A. (Bangladesh)
5OS1.3 Patient-centeredness from education to practice: Towards a personal style of 5OS2.3 Evidence for strengthening Universal Health Coverage in Uganda
context-sensitive patient centeredness Kiwanuka S. (Uganda)
Meers A. (Belgium)
5OS2.4 Closing remarks and overview of knowledge translation activities in the SPHIP
programme
5OS1.4 Understanding Patient-Centered Care approaches at primary health care level in Koot J. (The Netherlands)
sub-Saharan Africa: The case of Uganda
Waweru E. (Belgium)
12.00 Lunch Break & Poster Tour (12.30 - 13.30)
5OS1.5 Necessities, not luxuries: Lessons for Patient Centered Care learnt from mental
healthcare in resource-constrained settings 13.30 6OS1 - Building Capacity for Policy Influence and Health Systems
Sarkar N. (Belgium)
Management: Experiences from two European Union funded
17.00 5S3 - Health Policies Programmes in the Democratic Republic of Congo and in Uganda
Chairs: Susannah Mayhew (UK) and Sara Van Belle (Belgium) Organisers:
The RIPSEC (Uganda) and the SPEED (Democratic Republic of Congo) Partnerships
5S3.1 Supporting community health worker programs at scale: Lessons from policy
reforms shaping the evolution of India’s ASHA program Chair:
Ved R., Scott K., Gupta G., Ummer O., Srivastava A., George A. (India & South Africa) Suzanne Kiwanuka (Uganda)
5S3.2 Assessing and preparing health systems for integration of services in low- and 6OS1.1 Brief general introduction RIPSEC and SPEED program
middle-income countries – A systematic review Ssengooba F. (Uganda) & Criel B. (Belgium)
Topp S.M., Abimbola S., Joshi R., Negin J. (Australia)
6OS1.2 The strategy of learning and research health districts in a health systems
5S3.3 Models of engagement between the state and faith sector in Sub-Saharan Africa: strengthening perspective in the Democratic Republic of Congo: Clarification of the
A systematic review concept and review of similar experiences in Sub Saharan Africa
Whyle E.B., Olivier J. (South Africa) Michaux G. (Belgium)
5S3.4 State to the test of trust: Implementation of a public fee exemption policy in non- 6OS1.3 Theory of Change (ToC) as an inclusive methodology for planning, monitoring and
state facilities in Benin evaluating health district transformation in the Democratic Republic of the Congo
Dossou J.P., Marchal B. (Benin & Belgium) Ntambwe A. (RDC)
5S3.5 The politics of the basic benefit package reforms in Tajikistan: Health governance 6OS1.4 Research priority setting health systems development to advance universal health
constraints in neo-patrimonial settings coverage in Uganda: The stakeholder engagements and perspectives
Jacobs E. (The Netherlands & Switzerland) Ssennyonjo A. (Uganda)
6OS1.5 Policy implementation barometer in Uganda: What are barriers to policy
implementation? Development of a measuring instrument in Uganda
Hongoro C. (South Africa)
15.00 Coffee Break
22 www.ectmih2017.be www.ectmih2017.be 23Monday Tuesday Wednesday Thursday Friday Posters Monday Tuesday Wednesday Thursday Friday Posters
Gorilla 3 Pelican
15.30 6OS2 - Health Cooperation beyond Aid 10.30 1S1 - Diagnostics 1 - Serology and Hemo-Culture
Chairs: Stijn Deborggraeve (Belgium) and Pascal Mertens (Belgium)
Organisers:
Remco van de Pas, Board member 1S1.1 Re-defining blood culture for resource-limited settings: Developing draft target
Medicus Mundi International Network – Health for All (MMI), Basel, Switzerland product profiles for simplified diagnostics
Tim Roosen, Coordinator Dailey P., Osborn J., Martino R., Isaacs C., Dittrich S. (Switzerland & USA)
Be-Cause Health. Belgian Platform for International Health, Antwerpen, Belgium
1S1.2 Prospective evaluation of a rapid diagnostic test for gambiense human African
Chair: trypanosomiasis developed using recombinant antigens in the Democratic Republic
Thomas Schwarz (Switzerland) of the Congo
Lumbala C., Biéler S., Kayembe S., Makabuza J., Ongarello S., Ndung’u J.M. (Democratic
6OS2.1 Health Cooperation: Its relevance, legitimacy and effectiveness as a contribution to Republic of Congo & Switzerland)
achieving universal access to health
van de Pas R. (Belgium) 1S1.3 Finding Mimo: Developing an alternative rapid test for the serodiagnosis of visceral
leishmaniasis in Eastern African populations
6OS2.2 Health cooperation beyond aid: How we do it! Kühne V., Diro E., El-Safi S., Büscher P. (Belgium, Ethiopia & Sudan)
Lecture by the winner of a story contest
1S1.4 Visceral leishmaniasis: a combined wet-lab and in silico approach to the discovery
6OS2.3 Health systems strengthening in fragile settings – The role of international health of biomarkers of disease progression and post-chemotherapy relapse
cooperation Bremer Hinckel B.C., Marlais T., Airs S., Imamura H., Dujardin J.C., Falconar A.K., Bhattacharyya
van Belle E. (Belgium) T., Andersson B., Mertens P., Miles M.A. (Belgium, UK, Colombia & Sweden)
6OS2.4 Unpacking the ‘private’ sector and the new business model in international health
cooperation: Blurred boundaries and mandates 12.00 Lunch Break and Poster Tour (12.30 - 13.30)
Kapilashrami A. (UK)
13.30 1S2 - Diagnostics 2 - DNA-Based Assays
6OS2.5 Ending 50 years of bilateral cooperation in Latin America – Strategies for the future? Chairs: Isra Cruz (Switzerland) and Kevin Ariën (Belgium)
Van Bastelaere S. (Belgium)
1S2.1 Combination of random isothermal amplification and nanopore sequencing for rapid
17.00 4S4 – Biosocial Approaches in Disease Control identification of the causative agent of an outbreak
Chairs: Christiana Noestlinger (Belgium) and Dennis Perez (Cuba) Hansen S., Faye O., Faye M., Sanabani S.S., Pessôa R., Faye O., Böhlken-Fascher S.,
Sall A.A., Weidmann M., Czerny C.P., Abd El Wahed A. (Germany, Senegal, Brazil & UK)
4S4.1 Micro-epidemiology of malaria exposure in Central Vietnam: A mixed-methods case
study 1S2.2 Loop-mediated isothermal amplification for asymptomatic malaria diagnosis in the
Bannister-Tyrrell M., Xuan Xa N., Van Van N., Anh Dung V.K., Minh Hieu T., Van Hong N., Peruvian Amazon: Technical performance and pilot implementation in challenging
Kattenberg J.H., Rovira-Vallbona E., Thanh Duong T., Urgell A.R., Peeters Grietens K., Erhart A. field settings
(Belgium, Vietnam & The Gambia) Serra-Casas E., Manrique P., Ding X.C., Carrasco G., Alava F., Gave A., Contreras J.J.,
Rosas-Aguirre A., González I.J., Gamboa D., Rosanas-Urgell A. (Belgium, Peru &
4S4.2 Stigma among healthcare workers as a barrier to the use of TB services at Switzerland)
occupational health units in South Africa
Sommerland N., Wouters E., Masquillier C., Rau A., Engelbrecht M., Kigozi G., Uebel K. 1S2.3 Dry reagent-based loop-mediated isothermal amplification for confirmation of buruli
(Belgium & South Africa) ulcer using a portable fluorimeter
Beissner M., de Souza D.K., Maman I., Saar M., Zwirglmaier K., Wiedemann F., Bretzel G.,
4S4.3 Why would antiretroviral treatment adherence clubs work in the Western Cape Ndung’u J.M., Cruz I., Ablordey A. (Germany, Ghana, Togo & Switzerland)
Province, South Africa?
Mukumbang F.C., Van Belle S., Marchal B., Van Wyk B. (South Africa & Belgium) 1S2.4 Shotgun metagenomics as a tool for the rapid diagnosis and genotyping of Dengue
Lizarazo E.F., Couto N., Raangs E., Vincenti-Gonzalez M.F., Tovar R., Bethencourt S.,
4S4.4 Community participation in mosquito breeding site control: A multidisciplinary Grobusch M.P., Jaenisch T., Friedrich A., Tami A., Rossen J.W. (The Netherlands,
mixed methods study in Curaçao Venezuela & Germany)
Elsinga J., van der Veen H.T., Gerstenbluth I., Burgerhof J.G., Grobusch M.P., Dijkstra A.,
Tami A., Bailey A. (The Netherlands, Netherlands Antilles & India)
15.00 Coffee Break
24 www.ectmih2017.be www.ectmih2017.be 25Monday Tuesday Wednesday Thursday Friday Posters Monday Tuesday Wednesday Thursday Friday Posters
Pelican Toucan
15.30 3OS3 - Raising Standards and Quality of Parasite Diagnostics in Non- 10.30 2S1 - Surveillance of Arboviruses
Endemic Clinical Settings using Molecular and Lateral Flow Chairs: Christian Lengeler (Switzerland) and Veerle Vanlerberghe (Belgium)
Technologies
2S1.1 Enso and warmer temperatures are related with major outbreaks of Dengue in
Organisers: Venezuela
Dr. Jaya Shrivastava and Prof. Peter L Chiodini Vincenti-Gonzalez M.F., Lizarazo E.F., Friedrich A., Tami A., Grillet M.E. (The Netherlands
Institution: UKNEQAS Parasitology & Venezuela)
Organisations: University College London Hospitals and Public Health England
2S1.2 West Nile surveillance and response in Italy: A one health approach
Chairs: Parodi P., Rizzo C., Albonico M., Calzolari M., Chiari M., Capelli G., Casalone C., Angelini P.,
Jaya Shrivastava (UK) and Ingrid Felger (Switzerland) Monaco F., Maraglino F. (Italy)
3OS3.1 Molecular diagnosis of Leishmania species in European travel clinics 2S1.3 Effects of land use on the ecology of arbovirus-aedes mosquitoes in oil palm
Felger I. (Switzerland) plantation areas in Southeastern Côte d’Ivoire
Zahouli B.Z.J., Koudou G.B., Müller P., Malone D., Tano Y., Utzinger J. (Switzeralnd, Côte
3OS3.2 The first malaria molecular EQA scheme launched by UK NEQAS(P) [United d’Ivoire & UK)
Kingdom National External Quality Assessment Service Parasitology]
Shrivastava J. (UK) 2S1.4 Surveillance of mosquito-borne viruses with honey-baited FTA cards in an area of
low virus prevalence
3OS3.3 PCR as a first line diagnostic tool for diagnosis of intestinal parasitic infections in a Wipf N., Guidi V., Guedes D.R.D., Barbosa R.M.R., Tonolla M., Engler O., Müller P.
clinical laboratory (Switzerland & Brazil)
Verweij J.J. (The Netherlands)
2S1.5 Spatial dynamics of Chikungunya transmission in northern Venezuela: The first six
3OS3.4 RDTs in malaria diagnosis: Pushing new boundaries with lateral flow assays months of the epidemic
Weigl H.B. (USA) Lizarazo E.F., Vincenti-Gonzalez M.F., Diaz O., Ojeda N., Rangel M.A., Bethencourt S., Friedrich
A., Grobusch M.P., Tami A., Grillet M.E. (The Netherlands & Venezuela)
3OS3.5 Effective detection of asymptomatic malaria infections across geographically
diverse areas using loop-mediated isothermal amplification
Ding X.C. (Switzerland) 12.00 Lunch Break and Poster Tour (12.30 - 13.30)
17.00 3OS4 - New Developments in the Diagnosis of Imported Parasitic 13.30 2S2 - Vectors and Transmission of Arboviruses
Infections in Europe Chairs: Wim Van Bortel (Belgium) and Anna-Bella Failloux (France)
Organisers: 2S2.1 Antiviral drug-resistant Chikungunya viruses can be transmitted by their mosquito
Lisette van Lieshout (MSc, PhD), Dept. of Parasitology, Leiden University Medical Center vectors
(LUMC), RC Leiden, The Netherlands Delang L., Yen P., Vazeille M., Neyts J., Failloux A. (Belgium & France)
Marjan van Esbroeck (MD), Institute of Tropical Medicine (ITM), Antwerp, Belgium
2S2.2 HarmVect: A simulation based tool for pathway risk maps of invasive arthropods in
Chairs: Belgium - Case study: Aedes albopictus
Lisette van Lieshout (The Netherlands) and Marjan van Esbroeck (Belgium) Jansen F., Berkvens N., Deblauwe I., Van Loo T., Casteels H., Witters J., Van Damme V.,
Berkvens D. (Belgium)
3OS4.1 Nucleic acid amplification techniques, the future of malaria diagnosis?
Polley S.D. (UK) 2S2.3 Urbanisation drives the ecology of immature aedes mosquitoes in arbovirus-foci in
South-Eastern Côte d’Ivoire
3OS4.2 New developments in the diagnosis of schistosomiasis in European travellers and Zahouli B.Z.J., Koudou G.B., Müller P., Malone D., Tano Y., Utzinger J. (Switzerland, Côte
migrants: Will PCR and the detection of CCA and CAA replace microscopy? d’Ivoire & UK)
Van Lieshout L. (The Netherlands)
2S2.4 Invasive mosquito species surveillance in Belgium: Towards a structural plan
3OS4.3 Is there a need to screen asymptomatic migrants for parasitic infections? Deblauwe I., Demeulemeester J., Sohier C., Van Loo T., De Witte J., Madder M., Coosemans M.
Lier T. (Sweden & Norway) (Belgium, South Africa & The Netherlands)
3OS4.4 Will PCR replace microscopy in the diagnosis of imported intestinal parasites? 2S2.5 Expanding IR Mapper: Mapping insecticide resistance in Anopheles species, Aedes
Bisoffi Z. (Italy) aegypti and Aedes albopictus
Hadi M.P., Athinya D.K., Omondi S.A., Ochomo E.O. , Pates Jamet H. (Kenya & USA)
15.00 Coffee Break
26 www.ectmih2017.be www.ectmih2017.be 27Monday Tuesday Wednesday Thursday Friday Posters Monday Tuesday Wednesday Thursday Friday Posters
Toucan Gorilla 4
15.30 2S3 – Trematodes 10.30 8S3 - Sexual and Reproductive Health Rights
Chairs: Tine Huyse (Belgium) and Katja Polman (Belgium) Chairs: Susannah Mayhew (UK) and Esther Jurgens (The Netherlands)
2S3.1 Opisthorchis viverrini and a novel sister species in ducks share the same 8S3.1 Critical reflections on SRHR policies and law
intermediate snail and fish hosts in Central Vietnam Bosmans M., Gyselinck K., Van Bastelaere S., Bossyns P. (Belgium)
Dao T., Nguyen T., Dermauw V., Gabriel S., Dorny P. (Vietnam & Belgium)
8S3.2 Evaluating DANIDA’s global SRHR policy: Tracing accountability pathways at the
2S3.2 Human and animal trematode infections in a mobile pastoralist setting at Lake Chad: global policy level
Added value of a one health approach beyond zoonotic diseases research Mayhew S., Van Belle S. (Belgium)
Greter H., Batil A.A., Ngandolo B.N., Alfraroukh I.O., Moto D.D., Hattendorf J., Utzinger J.,
Zinsstag J. (Switzerland & Chad) 8S3.3 Body & rights – E-learning on sexual and reproductive health and rights for
stakeholders of development cooperation
2S3.3 Dynamics of S. haematobium and S. mansoni infection and morbidity: An eight-year Van Braeckel D., Blondeel K., the working group on sexual and reproductive health and rights of
follow-up study in a rural community in the north of Senegal Be-cause health, the Belgian platform on International Health (Belgium)
Meurs L., Mbow M., Vereecken K., Van den Broeck F., Mpabanzi L., Boon N., Huyse T.,
Polman K. (Belgium & Senegal) 8S3.4 Academic network for sexual and reproductive health and rights policy (ANSER)
Ivanova O., Degomme O., Michielsen K., Van Braeckel D. (Belgium)
2S3.4 Incorporating the ecology of intermediate hosts of schistosomiasis into spatially
explicit models of disease transmission in seasonal climates 8S3.5 Adressing unsafe abortion in Benin: Why is the current policy inappropriate?
Perez-Saez J., Mande T., Ceperley N., Bertuzzo E., Mari L., Gatto M., Rinaldo A. Dossou J.P., Kanhonou L., Bello K., Goufodji S. (Benin & Belgium)
(Switzerland & Italy)
2S3.5 Transmission and hybridisation dynamics of Schistosoma haematobium in the 12.00 Lunch Break and Poster Tour (12.30 - 13.30)
Senegal River Basin: No barrier breakdown between human and cattle
schistosomiasis?
Boon N., Mbow M., Paredis L., Maes T., Moris P., Mboup S., Volckaert F., Boissier J., 13.30 8S4 - Sexual and Reproductive Health
Polman K., Huyse T. (Belgium, Senegal & France) Chairs: Steven Callens (Belgium) and Bea Vuylsteke (Belgium)
8S4.1 Sexual practices among men who have sex with men in Kinshasa, DRC
17.00 2S4 - Onchocerciasis & Modelling Mukadi D., Sabi L., Nsalaba H., Dilu A., Lasse J., Manienga H., Nkuba A., Aloni M.,
Chairs: Niel Hens (Belgium) and Andreas Krüger (Germany) Muyembe-Tamfum J.J., Ahuka-Mundeke S. (DRC)
2S4.1 An update of blackfly (Diptera: Simuliidae) vectors and Onchocerca volvulus 8S4.2 Socioeconomic counters of intimate partner violence and impact on reproductive
transmission in Mahenge, south eastern Tanzania health services in India
Kalinga A., Krüger A., Pfarr K., De Witte J., Post R.J., Mwingira U., Colebunders B., Gogoi M., Kumar A. (India)
Dujardin J.C., O’Neill S., Hendy A. (Belgium, Germany, UK & Tanzania)
8S4.3 Post circumcision beliefs influencing sexual behaviour among men in
2S4.2 Onchocerciasis associated epilepsy in the Ituri and Tshopo province in the Wakiso district, Uganda
Democratic Republic of the Congo: A case-control study Kibira S.P.S., Atuyambe L.M., Sandøy I.F., Makumbi F.E., Daniel M. (Norway &
Mandro M., Hasan M., Tepage F., Rossy D., Ngave F., Mambandu G., Kashama J.M., Uganda)
Laudisoit A., Colebunders R., Suykerbuyk P. (DRC, Belgium & UK)
8S4.4 “Never trust an open door” - Controversies of sexual pleasure, pain and female
2S4.3 Mathematical modelling of transmission dynamics of Opisthorchis viverrini genital mutilation among African migrants in Belgium, the Netherlands and the UK
Bürli C., Harbrecht H., Odermatt P., Sayasone S., Chitnis N. (Switzerland & Lao PDR) Zewolde S., Florquin S., Bos M., Dubourg D., Richard F., O’Neill S. (UK, Belgium & The
Netherlands)
2S4.4 Estimating age-time dependent malaria force of infection accounting for
unobserved heterogeneity
Hens N., Mugenyi L., Abrams S. (Belgium & Uganda) 15.00 Coffee Break
2S4.5 Mathematical modelling of dog rabies transmission in N’Djaména, Chad
Laager M., Mbilo C., Léchenne M., Zinnstag J., Chitnis N. (Switzerland)
28 www.ectmih2017.be www.ectmih2017.be 29Monday Tuesday Wednesday Thursday Friday Posters Monday Tuesday Wednesday Thursday Friday Posters
Gorilla 4 Gorilla 5
15.30 8OS1 - Abortion and Post Abortion Care: Politics, Religion, Public 10.30 3OS5 - Nodding Syndrome: Interdisciplinary Findings and Ways
Health, Health Care and Legal Systems forward in Prevention and Treatment
Organisers: Organisers:
Maria Lisa Odland, Norwegian University of Science and Technology, Trondheim, Norway Sarah O’Neill, Medical Anthropology Unit, Institute of Tropical Medicine, Belgium
Robert Colebunders, Global Health Institute, University of Antwerp, Belgium
Chairs: Koen Peeters, Medical Anthropology Unit, Institute of Tropical Medicine, Belgium
Berit Austveg (Norway) and Elisabeth Darj (Norway)
Chairs:
8OS1.1 Use of manual vacuum aspiration in the treatment of incomplete abortions: A Patrick Suykerbuyk (Belgium) and Koen Peeters (Belgium)
cross sectional study from three public hospitals in Malawi
Odland M.L. (Norway) 3OS5.1 Nodding syndrome clinical manifestations and treatment
Idro R. (Uganda)
8OS1.2 International actors’ legitimacy seeking practices in Malawi’s abortion law reform
Kloster M. (Norway) 3OS5.2 Nodding Syndrome: Etiology remains unknown
Winkler A. (Norway)
8OS1.3 Working on the edge: Ambiguity, responsibility and ethical dilemmas faced by
abortion providers in Ethiopia 3OS5.3 How politics and research fatigue challenge NS control in Uganda
McLean E. (Norway) Irani J. (Belgium)
8OS1.4 Beyond restrictive public health policies: The role of misoprostol in the perception 3OS5.4 High prevalence of epilepsy and onchocerciasis after 20 years of ivermectin use in
and access to illegaly induced abortion in Burkino Faso four villages of the Mahenge area in Tanzania
Drabo S. (Norway) Mmbando B. (Tanzania)
17.00 8S5 – HIV 3OS5.5 Community-based perceptions of ivermectin in the Sanaga basin of Cameroon
Chairs: Brian Van Wyck (South Africa) and Thérèse Delvaux (Belgium) Ronse M. (Belgium)
3OS5.6 Nodding Syndrome is preventable
8S5.1
Same day ART initiation versus clinic-based pre-ART assessment and counselling Colebunders R. (Belgium)
for individuals newly tested HIV-positive during community-based HIV testing in
rural Lesotho – A randomized controlled trial (CASCADE trial): Preliminary results
Labhardt N.D., Ringera I., Lejone T.I., Klimkait T., Muhairwe J., Cerutti B., Glass T.R. 12.00 Lunch Break and Poster Tour (12.30 - 13.30)
(Switzerland & Lesotho)
8S5.2 Prevention of mother-to-child transmission of HIV: Postpartum adherence to option B+ 13.30 9S1 - Emerging Voices: Making Promises, breaking Commitments:
until 18 months in Western Uganda What is the Role of Health Policy and Systems Researchers in
Theuring S., Decker S., Rempis E., Schnack A., Braun V., Rubaihayo J., Busingye P., transforming Political Commitments into better Health Systems?
Tumwesigye N.M., Harms G. (Germany & Uganda)
Chair:
8S5.4 Screening of human Papillomavirus, cervical cytological abnormalities and Seye Abimbola (Editor in Chief, BMJ Global Health, UK)
associated risk factors in HIV-positive and HIV-negative women in Rwanda
Manzi O.M. (Rwanda) Speakers/Debaters:
Khalid F. (Health Financing Consultant, Prime Minister’s National Health Insurance
8S5.5 HIV prevalence declines in Southern Africa: Have we misread the landscape? Program, Pakistan, EV 2016)
Loevinsohn M.E. (The Netherlands) Choonara S. (Southern African AIDS Trust, Johannesburg, South Africa, EV 2014)
Scott K. (Independent Consultant, Bangalore, India & Johns Hopkins University, USA, EV
2014)
Prashanth N.S., (Assistant Director Research, Institute of Public Health Bangalore, India,
EV 2010)
Bermejo R. (Health Policy and Systems Researcher, PhD student - Institute of Tropical
Medicine, Antwerp, EV 2010)
15.00 Coffee Break
30 www.ectmih2017.be www.ectmih2017.be 31You can also read
